Dr. Sharon G. Adler, MD

Dr. Adler practices at Trc Harbor UCLA Mfi Total Renal Dialysis Center in Torrance, California.

Dr. Adler's NPI, 1467431122, was assigned on January 11, 2006. Dr. Adler graduated from SUNY Downstate Health Sciences University in 1976. Dr. Adler's California license number on file is G35663.

Dr. Adler's primary practice is Trc Harbor UCLA Mfi Total Renal Dialysis Center, at 21836 Normandie Ave, Torrance, CA 90502 in Los Angeles County. The practice phone is (310) 533-0413.

Dr. Adler's primary practice is Trc Harbor UCLA Mfi Total Renal Dialysis Center in Torrance, California. Dr. Adler is also affiliated with Harbor-UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Adler to 1 more dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adler practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Adler's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Adler is board certified in internal medicine by the American Board of Internal Medicine. Dr. Adler has a license on file in California.

CMS data shows 145 Medicare services from Dr. Adler across 2 procedure codes in 2024, for 21 Medicare patients. Medicare paid $41,243 for them. Every service was in an office.

CMS counts 21 Medicare patients who saw Dr. Adler in 2024. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 9.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adler's median patient age at 63, with 44% women.

In 2024, Dr. Adler wrote 300 Medicare Part D claims for 27 patients. 76% of them were for generic drugs. CMS names the drug for 165 of them, across 9 drugs with 11 or more claims each, at $111,470 in total drug cost. In 2023, CMS named 75 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 39 out of 100 for Dr. Adler for performance year 2024, reported as part of a group. Dr. Adler accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 90 papers to Dr. Adler, published from 2007 to 2024. 2022 was the busiest year, with 7. The most frequent topics are Diabetic Nephropathies, Kidney Failure, Chronic and Kidney Glomerulus. Dr. Adler has published most often in Kidney Int. Dr. Adler's most frequent co-authors are Cynthia C. Nast, MD, Keisha Lashan Gibson, MD and Debbie Sue Gipson, MD.

Dmand AI links Dr. Adler to 1 clinical trial. Conditions studied include Diabetic Nephropathies and Diabetes Complications. Open Payments lists research payments to Dr. Adler that name 1 trial.

CMS Open Payments shows 114 general payments to Dr. Adler from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. AstraZeneca Pharmaceuticals LP paid the most, $18,354. It also lists 12 research payments totaling $3,152 from 2017 to 2019, naming 1 clinical trial.

Dr. Adler graduated from SUNY Downstate Health Sciences University in 1976.

Dr. Adler is in network with 15 carriers, including United Healthcare, Elevance and HCSC. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.